The current valuation score of Prime Medicine Inc is 6.00, ranking 366 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.44, which is -70.74% below the recent high of -0.71 and -491.94% above the recent low of -14.45.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.